Anson Funds Management LP - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 33 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Anson Funds Management LP ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$768,000
-80.1%
5,409,500
-70.5%
0.24%
-42.0%
Q3 2016$3,852,00018,340,0000.41%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$105,0000.06%
Benin Management CORP 83,000$58,0000.03%
CONDOR CAPITAL MANAGEMENT 121,324$85,0000.02%
First Heartland Consultants, Inc. 30,000$21,0000.01%
FCG ADVISORS, LLC 15,000$11,0000.01%
Advisory Services Network, LLC 22,000$16,0000.01%
Virtu KCG Holdings LLC 346,822$243,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,000$126,0000.00%
Moors & Cabot, Inc. 18,000$12,0000.00%
Corbenic Partners LLC 1,600$1,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders